Application of 31P Magnetic Resonance Spectroscopy to Observation of Phospholipid Concentration Changes in Blood Serum, Plasma, Peripheral Blood Mononuclear Cells and Bone Marrow Mononuclear Cells from Patients with Hematological Cancers

• Autorzy: Tuz M. , Kuliszkiewicz-Janus M. , Baczyński S.
• Konferencja: 1st Symp. on NMR in Chemistry, Biology and Medicine; 8-10 Semptember, Warsaw, Poland. Issue dedicated to honour Prof. Witanowski
• Języki publikacji: EN

Abstrakty

EN

Phospholipids play an important role in biological events of progression of cancer. 31P magnetic resonance spectroscopy (MRS) can be a powerful method for non-invasive investigations aiming at explanation of phospholipid mechanisms in tumor tissues and body fluids. 31PMRS was applied to serum, serum with added sodium salt of cholic acid, and phospholipid extracts from plasma, peripheral blood mononuclear cells (PBMC) and bone marrow mononuclear cells (BMMC) from healthy volunteers and patients with hematological cancers. Concentrations of phospholipids were derived from integral intensities of the 31P signals. Observations indicated that phospholipid concentration changes in sera, plasma, PBMC, and BMMC can discriminate between non-responding and responding patients, as well as healthy volunteers. The aim of this review is to show how our scientific group applies 31P MR spectroscopy to study phospholipid metabolism in blood serum, plasma, peripheral blood mononuclear cells and bone marrow mononuclear cells of patients with hematological cancers.

Słowa kluczowe

EN

31PMRS in vitro; phospholipids; hematological cancers

• Wydawca: Polskie Towarzystwo Chemiczne
• Czasopismo: Polish Journal of Chemistry
• Rocznik: 2006
• Tom: Vol. 80, nr 7
• Strony: 1009--1019
• Opis fizyczny: Bibliogr. 14 poz., rys.

Twórcy

autor

Tuz M.

autor

Kuliszkiewicz-Janus M.

autor

Baczyński S.

• Institute of Experimental Physics, University of Wrocław, Pl. Maxa Borna 9, 50-204 Wrocław, Poland

Bibliografia

• 1. Schiller J. and Arnold K., Med. Sci. Monit., 8, MT205 (2002).
• 2. Merchant T.E., Meneses P., Gierke L.W, Den Otter W. and Glonek T., Br. J. Cancer, 63, 693 (1991).
• 3. Merchant T.E., de Graaf P. W, Minsky B.D, Obertop H. and Glonek T., NMR Biomed., 6,187 (l 993).
• 4. Merchant T.E., Kasimos J.N, de Graaf P. W, Minsky B.D, Gierke L.W. and Glonek T, Int. J. Colorect. Dis., 6, 121 (1991).
• 5. Raffelt K., Moka D, Sullentrop F, Dietlein M, Hahn J. and Schicha H, NMR Biomed., 13, 8 (2000).
• 6. Sullentrop F, Moka D, Neubauer S, Haupt G, Engelmann U, Hahn J. and Schicha H, NMR Biomed.,15, 60 (2002).
• 7. Kuliszkiewicz-Janus M. and Baczyński S, NMR Biomed., 8, 127 (1995).
• 8. Kuliszkiewicz-Janus M. and Baczyński S, Magn. Reson. Med., 35, 449 (1996).
• 9. Kuliszkiewicz-Janus M, Janusz W. and Baczyński S, Anticancer Res., 16, 1587 (1996).
• 10. Kuliszkiewicz-Janus M. and Baczyński S, Biochim. Biophys. Acta, 1360, 71 (1997).
• 11. Kuliszkiewicz-Janus M, Baczyński S. and Jurczyk A, Med. Sci. Monit., 10, CR485 (2004).
• 12. Folch J, Lees M. and Sloan Stanley G.H, J. Biol. Chem., 226,497 (1957).
• 13. Bradamante S, Barchiesi E, Barenghi L. and Zoppi F, Anal. Biochem., 185, 299 (1990).
• 14. Kuliszkiewicz-Janus M, Tuz M. and Baczyński S, MAGMA, 16 (supl. 1), Abstract 520 (2004).